Recordis ABActive

559166-3298Limited company (AB)Registered 2018STOCKHOLM

Key figures

150 000 kr−59,9%
Revenue 2025
−37,7%
Average annual change 2019–2025
01 m2 m3 m2019202020212022202320242025

Key figures

2025
Balance structure
Current assetsFixed assetsLiabilitiesEquity
01 m2 m2019202020212022202320242025

Dividend

proposed
2025

Proposed dividend 77 000 kr.

History
202577 000 kr
2024225 000 kr
2023224 245 kr
2022262 469 kr
20211 078 538 kr
2020599 685 kr

Taken directly from the proposed appropriation of profit in the annual report (not calculated).

Summary of annual reports2019–2025
2019202020212022202320242025
Balance sheet — assets
Total current assets1 579 5431 465 1841 677 134562 469786 713756 010839 057
Total non-current assets156 585108 54200———
Total assets1 736 1271 573 7251 677 134562 469786 714756 010839 057
Balance sheet — liabilities and equity
Current liabilities660 622674 040298 5950262 469230 206460 649
Non-current liabilities———————
Total liabilities660 622674 040298 5950262 469230 206460 649
Share capital50 00050 00050 00050 00050 00050 00050 000
Retained earnings of previous periods———————
Profit for the year (equity)1 025 505599 6851 078 538262 469224 245225 80477 604
Total equity1 075 505899 6851 378 539562 469524 245525 804378 408
Income statement
Sales revenue2 558 0001 780 0001 930 000696 000578 000374 000150 000
Operating profit1 316 224756 8881 316 493334 447272 670272 97792 250
Profit before income tax1 314 747762 9561 359 503333 019281 214282 55496 770
Profit for the reporting year1 025 505599 6851 078 538262 469224 245225 80477 604
Labour costs667 086872 227456 27264 98824 8096 566744
Depreciation of non-current assets———————
Other indicators
Employees1111111
Proposed dividend—599 6851 078 538262 469224 245225 00077 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Summary: Recordis AB

Overview

Recordis AB (org. no. 559166-3298) is a limited company (AB). The company was registered in 2018 and has existed for 8 years. Registered seat: Stockholm. Industry according to Statistics Sweden: research and experimental development on biotechnology (SNI 72101).

Economy

Net sales in financial year 2025 were 150 000 kr, down 59,9 % on the previous year (374 000 kr). From 2019 to 2025, net sales declined by an average of 37,7 % per year. This is the lowest net sales among the reported years (2019–2025). Net profit for 2025 was 77 604 kr (51,7 % of net sales). The company was profitable in all 7 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 150 000 kr. At the end of financial year 2025, total assets were 839 057 kr and equity 378 408 kr (equity ratio 45,1 %). The annual report for 2025 proposes a dividend of 77 000 kr.

Sources and freshness

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-10-12. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Similar companies